We’re excited to share our latest work on tumour microdialysis, a powerful technique for measuring unbound, pharmacologically active drug concentrations directly within brain tumours like glioblastoma.
Unlike systemic plasma levels, microdialysis provides a true picture of drug penetration into the tumour helping to uncover heterogeneous distribution and the impact of the blood-tumour barrier.
Our approach involves precise stereotaxic surgery, tumour validation, and sampling from both tumour and healthy brain tissue enabling direct, comparative pharmacokinetic analysis.
📊 The results? Significant differences in drug exposure between tumour core and surrounding tissue.
👉 Swipe through the carousel to explore our process and findings.

🔗 www.pharmidex.com
The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.
